Suchergebnisse - "Conradie, Francesca"

PubPharm (96)

1

A cohort study of Post COVID-19 Condition across the Beta, Delta and Omicron waves in South Africa: 6-month follow up of hospitalised and non-hospitalised participants

enthalten in: bioRxiv.org | 2024

von Jassat, W. | Mudara, C. | Vika, C. | +15

2

Clinical implications of molecular drug resistance testing for Mycobacterium tuberculosis : a 2023 TBnet/RESIST-TB consensus statement

enthalten in: The Lancet. Infectious diseases | 2023

von Domínguez, J. | Boeree, M. | Cambau, E. | +54

ErratumIn: Lancet Infect Dis. 2023 Mar 28;:. - PMID 37001542

3

A cohort study of post-COVID-19 condition across the Beta, Delta, and Omicron waves in South Africa : 6-month follow-up of hospitalized and nonhospitalized participants

enthalten in: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2023

von Jassat, W. | Mudara, C. | Vika, C. | +15

4

Southern African HIV Clinicians Society 2023 Guideline for post-exposure prophylaxis : Updated recommendations

enthalten in: Southern African journal of HIV medicine | 2023

von Horak, J. | Venter, W. | Wattrus, C. | +7

5

Evaluation of two short standardised regimens for the treatment of rifampicin-resistant tuberculosis (STREAM stage 2) : an open-label, multicentre, randomised, non-inferiority trial

enthalten in: Lancet (London, England) | 2022

von Goodall, R. | Meredith, S. | Nunn, A. | +65

CommentIn: Lancet. 2022 Nov 26;400(10366):1823-1825. - PMID 36368335

6

Sequencing Mycobacteria and Algorithm-determined Resistant Tuberculosis Treatment (SMARTT) : a study protocol for a phase IV pragmatic randomized controlled patient management strategy trial

enthalten in: Trials | 2022

von Van Rie, A. | De Vos, E. | Costa, E. | +24

7

Post-COVID-19 condition 3 months after hospitalisation with SARS-CoV-2 in South Africa : a prospective cohort study

enthalten in: The Lancet. Global health | 2022

von Dryden, M. | Mudara, C. | Vika, C. | +13

CommentIn: Lancet Glob Health. 2022 Sep;10(9):e1210-e1211. - PMID 35961329

8

Bedaquiline-Pretomanid-Linezolid Regimens for Drug-Resistant Tuberculosis

enthalten in: The New England journal of medicine | 2022

von Conradie, F. | Bagdasaryan, T. | Borisov, S. | +43

CommentIn: N Engl J Med. 2022 Sep 1;387(9):842-843. - PMID 36053511

9

Treatment outcomes 24 months after initiating short, all-oral bedaquiline-containing or injectable-containing rifampicin-resistant tuberculosis treatment regimens in South Africa : a retrospective cohort study

enthalten in: The Lancet. Infectious diseases | 2022

von Ndjeka, N. | Campbell, J. | Meintjes, G. | +12

CommentIn: Lancet Infect Dis. 2022 Jul;22(7):923-924. - PMID 35512717

10

Proposed Linezolid Dosing Strategies to Minimize Adverse Events for Treatment of Extensively Drug-Resistant Tuberculosis

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2022

von Imperial, M. | Nedelman, J. | Conradie, F. | +1

1
2
3
4
5
6
7
8
9
10
Nächster »
[10]